The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia

被引:0
|
作者
Morabito, Fortunato [1 ]
Tripepi, Giovanni [2 ]
Mauro, Francesca Romana [3 ]
Laurenti, Luca [4 ]
Reda, Gianluigi [5 ,6 ]
Moia, Riccardo [7 ]
Condoluci, Adalgisa [8 ,9 ]
Vincelli, Iolanda [10 ]
Chiarenza, Annalisa [11 ]
Vigna, Ernesto [12 ]
Martino, Enrica Antonia [12 ]
Bruzzese, Antonella
Mezzatesta, Sabrina [2 ]
Laureana, Roberta [13 ]
Cutrona, Giovanna [14 ]
Di Raimondo, Francesco
Fronza, Gilberto [15 ]
Zucchetto, Antonella [16 ]
Bomben, Riccardo [16 ]
Rossi, Francesca Maria [16 ]
Olivieri, Jacopo [17 ]
Zaja, Francesco [18 ]
Rossi, Davide [8 ,9 ]
Gaidano, Gianluca [7 ]
Del Principe, Maria Ilaria [13 ]
Ilariucci, Fiorella [19 ]
Del Poeta, Giovanni [13 ]
Ferrarini, Manlio [14 ]
Neri, Antonino [20 ]
Gattei, Valter [16 ]
Gentile, Massimo [12 ,21 ]
机构
[1] AO ASP Cosenza, Biotechnol Res Unit, Aprigliano, I-87100 Cosenza, Italy
[2] CNR, Ist Fisiol Clin CNR, Reggio Di Calabria, Italy
[3] Sapienza Univ, Dept Cellular Biotechnol & Hematol, Rome, Italy
[4] Catholic Univ Hosp A Gemelli Rome, Dept Hematol, Rome, Italy
[5] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy
[6] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Hematol CTMO, Milan, Italy
[7] Univ Piemonte Orientale, Dept Translat Med, Div Haematol, Novara, Italy
[8] Oncol Inst Southern Switzerland, Bellinzona, Switzerland
[9] Inst Oncol Res, Bellinzona, Switzerland
[10] Hematol Unit Reggio Calabria, Reggio Di Calabria, Italy
[11] Univ Catania, Osped Ferrarotto, Div Ematol, Catania, Italy
[12] AO Cosenza, Dept Oncohematol, Hematol Unit, Cosenza, Italy
[13] Univ Roma Tor Vergata, Dipartimento Biomed & Prevenz, Ematol, Rome, Italy
[14] Osped Policlin San Martino IRCCS, UO Mol Pathol, Genoa, Italy
[15] IRCCS Osped Policlin San Martino, Mutagenesis & Canc Prevent Unit, Genoa, Italy
[16] Ctr Riferimento Oncol Aviano CRO IRCCS, Clin & Expt Onco Hematol Unit, Aviano, Italy
[17] Azienda Osped Univ S Maria Misericordia, Ctr Trapianti & Terapie Cellulari, Clin Ematol, Udine, Italy
[18] Univ Trieste, Haematol, Trieste, Italy
[19] Azienda USL IRCCS Reggio Emilia, Hematol Unit, Reggio Emilia, Italy
[20] Azienda USL IRCCS Reggio Emilia, Sci Directorate, Reggio Emilia, Italy
[21] Univ Calabria, Dept Pharm Hlth & Nutr Sci, Arcavacata Di Rende, Italy
基金
瑞士国家科学基金会; 欧洲研究理事会;
关键词
PROGRESSION; RISK;
D O I
10.1002/ajh.26927
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E157 / E160
页数:4
相关论文
共 50 条
  • [31] Spotlight on ibrutinib and its potential in frontline treatment of chronic lymphocytic leukemia
    Khan, Maliha
    Gibbons, Jamie L.
    Ferrajoli, Alessandra
    ONCOTARGETS AND THERAPY, 2017, 10 : 1909 - 1914
  • [32] Deep targeted sequencing of TP53 in chronic lymphocytic leukemia: clinical impact at diagnosis and at time of treatment
    Brieghel, Christian
    Kinalis, Savvas
    Yde, Christina W.
    Schmidt, Ane Y.
    Jonson, Lars
    Andersen, Michael A.
    da Cunha-Bang, Caspar
    Pedersen, Lone B.
    Geisler, Christian H.
    Nielsen, Finn C.
    Niemann, Carsten U.
    HAEMATOLOGICA, 2019, 104 (04) : 789 - 796
  • [33] Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic index
    Kleinstern, Geffen
    O'Brien, Daniel R.
    Li, Xing
    Tian, Shulan
    Kabat, Brian F.
    Rabe, Kari G.
    Norman, Aaron D.
    Yan, Huihuang
    Vachon, Celine M.
    Boddicker, Nicholas J.
    Call, Timothy G.
    Parikh, Sameer A.
    Bruins, Laura
    Bonolo de Campos, Cecilia
    Leis, Jose F.
    Shanafelt, Tait D.
    Ding, Wei
    Cerhan, James R.
    Kay, Neil E.
    Slager, Susan L.
    Braggio, Esteban
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (08) : 906 - 917
  • [34] Mutational Status of the TP53 Gene As a Predictor of Response and Survival in Patients With Chronic Lymphocytic Leukemia: Results From the LRF CLL4 Trial
    Gonzalez, David
    Martinez, Pilar
    Wade, Rachel
    Hockley, Sarah
    Oscier, David
    Matutes, Estella
    Dearden, Claire E.
    Richards, Sue M.
    Catovsky, Daniel
    Morgan, Gareth J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (16) : 2223 - 2229
  • [35] Types of second primary cancers influence survival in chronic lymphocytic and hairy cell leukemia patients
    Zheng, Guoqiao
    Chattopadhyay, Subhayan
    Sud, Amit
    Sundquist, Kristina
    Sundquist, Jan
    Foersti, Asta
    Houlston, Richard S.
    Hemminki, Akseli
    Hemminki, Kari
    BLOOD CANCER JOURNAL, 2019, 9 (4)
  • [36] How to Choose the Best Treatment and Testing for Chronic Lymphocytic Leukemia in the Tsunami of New Treatment Options
    Yeung, Cecilia C. S.
    Shadman, Mazyar
    CURRENT ONCOLOGY REPORTS, 2019, 21 (08)
  • [37] PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma
    Sailer, Verena
    Holmes, Emily Eva
    Gevensleben, Heidrun
    Goltz, Diane
    Droege, Freya
    Franzen, Alina
    Dietrich, Joern
    Kristiansen, Glen
    Bootz, Friedrich
    Schroeck, Andreas
    Dietrich, Dimo
    CLINICAL EPIGENETICS, 2017, 9
  • [38] Heart Dose Is an Independent Dosimetrie Predictor of Overall Survival in Locally Advanced Non-Small Cell Lung Cancer
    Speirs, Christina K.
    DeWees, Todd A.
    Rehman, Sana
    Molotievschi, Alerson
    Velez, Maria A.
    Mullen, Daniel
    Fergus, Sandra
    Trovo, Marco
    Bradley, Jeffrey D.
    Robinson, Cliff G.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (02) : 293 - 301
  • [39] Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome
    Albi, Elisa
    Baldoni, Stefano
    Aureli, Patrizia
    Dorillo, Erica
    Del Papa, Beatrice
    Ascani, Stefano
    Di Ianni, Mauro
    Falzetti, Franca
    Sportoletti, Paolo
    TUMORI, 2017, 103 : S37 - S40
  • [40] Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment-free and overall survival in Chronic Lymphocytic Leukaemia
    Crassini, Kyle R.
    Zhang, Eva
    Balendran, Shalini
    Freeman, Jane A.
    Best, O. Giles
    Forsyth, Cecily J.
    Mackinlay, Naomi J.
    Han, Ping
    Stevenson, William S.
    Mulligan, Stephen P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (01) : 97 - 101